Our Location
304 North Cardinal St.
Dorchester Center, MA 02124
Product Name: Axinix
Generic Name: Axitinib
Formulation: Tablets
Available pack size: 1mg and 5mg
Available strength: 180 and 60
Wechat and whatsapp: +8801304498958
Axinix 5mg tablet, also known as Axitinib, is a medicine that falls under targeted therapy. It’s a tyrosine kinase inhibitor (TKI) and targets specific receptors, like VEGFR. Inlyta is Axitinib’s brand name.
Doctors use it for the treatment of advanced renal cell carcinoma after failure of one prior treatment. It can rapidly absorb and maximal plasma concentration.
It hinders the development of cancerous blood vessels, ultimately slowing down the growth and progression of tumors.
Advanced Renal Cell Carcinoma (RCC) is a form of kidney cancer that has spread to nearby tissues or other organs. When one prior systemic therapy has not been successful, it becomes a valuable treatment option.
It works against cancer by focusing on specific proteins, called tyrosine kinases, especially VEGFR-1, VEGFR-2, and VEGFR-3. These proteins are crucial for the growth of blood vessels in tumors.
By blocking these proteins, it hinders the creation of new blood vessels in tumors. Making them starve of necessary nutrients and oxygen. This process slows down tumor growth and stops the disease from advancing.
The amount of dose of axitinib you take and how it’s used can differ depending on how your body responds. Your healthcare provider will give you specific instructions to follow. They might need to adjust the dosage based on how well you handle the medicine and how effective it is for you. It’s important to keep in touch with your healthcare team regularly to make sure you’re getting the best treatment for your needs.
Generally, the standard starting axitinib dose is 5mg, taken orally twice daily. However, physicians may adjust the dosage based on the patient’s response and tolerance to the medication. It is available in a 180 s pot and a 60 s pot.
Effective side effect management is vital for patients to successfully continue their Axitinib treatment. Here are some strategies to help with common side effects:
The success rate of axitinib in cancer treatment has been remarkable in certain cases. Clinical trials have shown positive outcomes, particularly in advanced renal cell carcinoma (RCC) and certain types of thyroid cancer. Axitinib’s targeted approach has demonstrated significant improvements in progression-free survival (PFS) and overall survival (OS) rates.
It was found when compared to traditional treatments in these specific cancer types. However, it is essential to note that individual responses to the drug can vary. All patients may not experience the same level of success.
Although the success rate is remarkable axitinib life expectancy is still not clear. No medical research clinical trials or real field experiment could not determine it yet
The axitinib cost can vary based on factors like insurance, treatment duration, and personal finances. To understand potential costs and explore insurance coverage or financial assistance, it’s crucial to discuss with your healthcare team.
For safe and effective use of Axitinib, it’s crucial to follow these guidelines:
Axitinib is not a chemotherapy drug. It is a tyrosine kinase inhibitor. Doctors use this drug to treat renal cell carcinoma.
Traditional chemotherapy works by killing rapidly dividing cells, including cancer cells. But it can also affect healthy cells in the body.
In contrast, targeted therapies like axitinib specifically target certain proteins or receptors involved in cancer cell growth and proliferation.
It targets vascular endothelial growth factor receptors (VEGFRs). It also disrupts tumor angiogenesis. This is the process of forming new blood vessels that supply nutrients to tumors.
Doctors use targeted therapies like axitinib to treat patients with advanced renal cell carcinoma (RCC). It is also used to treat certain types of thyroid cancer. They offer a more focused approach to cancer treatment and may have a different potential risk profile. So that patients understand the specific therapies recommended for their type and stage of cancer.
The duration of Axitinib’s effect can vary from person to person. It depends on several factors, including the stage of cancer, and individual response to the medication. It also depends on the overall health of the patient.
In clinical trials and real-world experience, it has shown effectiveness in slowing the progression of the disease. In some cases, it leads to tumor shrinkage.
The oncologist decides the treatment duration of axitinib. This duration depends on how the patient respond to medication and whether it is under control.
In some cases, patients may continue taking it for an extended period. If it continues to provide benefits and if the side effects are manageable.
Patients need to have regular follow-up visits with doctors during treatment. Doctors will monitor the response to Axitinib and address any concerns or potential side effects.
The healthcare team will evaluate the overall effectiveness of the treatment and may adjust the treatment plan if necessary. It’s important to note that cancer treatments are constantly evolving, and new therapies may become available over time.
So patients should work closely with their medical team to determine the best treatment approach for their specific situation.
You must be logged in to post a review.
Reviews
There are no reviews yet.